This study from Fudan University School of Public Health and the Shanghai CDC, published in Human Vaccines & Immunotherapeutics, leveraged the city’s immunization registry to conduct a retrospective cohort analysis of children born between September 1, 2018 and August 30, 2023. Children were classified by the COVID-19 phase at their expected vaccination dates (pre/post-epidemic, baseline, epidemic). Three pertussis-containing vaccines were included, namely, DTP, DTP-Hib, and DTP-IPV-Hib. Kaplan–Meier estimators and multivariable Cox models showed marked declines in timeliness when vaccination windows coincided with epidemic phases—for example, at 2 months the probability of timely vaccination was 0.89 (95% CI 0.86–0.92) during baseline vs 0.53 (95% CI:0.51–0.55) during epidemic periods; hazard ratios for timely vaccination at 3 and 5 months decreased by 12% (HR=0.88, 95% CI:0.86–0.90) and 9% (HR=0.91, 95% CI:0.87–0.94) in baseline vs pre/post, and by 49% (HR=0.51, 95% CI:0.49–0.53) and 57% (HR=0.43, 95% CI:0.40–0.46) during epidemic periods. Findings underscore the need for targeted catch-up and service-continuity measures to mitigate disruptions to routine childhood immunization.
HPV Vaccination Policies and Implementation for Adolescents in Low- and Middle-Income Countries: A Scoping Review
This scoping review, published in The Lancet Regional Health – Western Pacific by Prof. Qing LIU and team from Chongqing Medical University, examined adolescent HPV vaccination policies and implementation experiences across 84 low- and middle-income countries (LMICs) that had incorporated HPV vaccination into their national immunization programs, and synthesized implementation evidence available through July 2025, with a focus on adolescents aged 9–14 years. The review found substantial policy convergence in target age groups, school-based delivery, and free vaccination, while important differences remained in gender eligibility, vaccine type, and financing mechanisms.Vaccination schedules have also become progressively simpler, with nearly half of LMICs adopting single-dose regimens. Despite continued policy progress, substantial coverage gaps remain. Among countries reporting complete-dose coverage in 2024, only 9.8% achieved the WHO target of 90% of girls being fully vaccinated by age 15.Trend analyses suggested that school-based programs generally demonstrated more stable coverage over time. The study suggests that school-based vaccination, complemented by mixed delivery strategies and simplified single-dose schedules, may provide a promising pathway to expand HPV vaccine coverage and advance cervical cancer elimination in resource-limited settings.